Clinical trial
Multi-center Double-blind Randomized Controlled Trial to Evaluate Effectiveness and Safety of Co-administered Traumeel® / Zeel® Intra-articular Injections vs Placebo in Patients With Moderate-to-Severe Pain With Osteoarthritis of the Knee
NCT01887678 is registered in ClinicalTrials.gov with Biologische Heilmittel Heel GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center Double-blind Randomized Controlled Trial to Evaluate Effectiveness and Safety of Co-administered Traumeel® / Zeel® Intra-articular Injections vs Placebo in Patients With Moderate-to-Severe Pain With Osteoarthritis of the Knee
- Lead sponsor
- Biologische Heilmittel Heel GmbH
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- January 31, 2014
- Enrollment
- 287 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.